Stock Events

Stock Events

UroGen Pharma (URGN) Q1 2025 Earnings

10MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.97

-0.83

-0.69

-0.55

Details

Expected EPS

-0.719714

Actual EPS

-0.8

Surprise EPS

-0.08

Surprise Percent

+11.16%

Description

UroGen Pharma (URGN) has reported earnings of -0.8 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.